Lucheng Zhu - Publications, H-index & Citations

Lucheng Zhu

Guizhou University

18H指数

87论文数

967被引数

收录论文 25

发表时间

Mechanism of action of dual feedback factors on assembly knowledge transfer efficiency of energy storage devices 双反馈因素对储能器件组装知识转移效率的作用机制

Computers in Human Behavior Reports

IF5.8

2026-04-17

OAAI

Lucheng Zhu; Ling He; Jin He; Guanci Yang; Yujia Chen; Zhijun Yue

Hyperthermia correlates with low incidence of radiation pneumonitis after thoracic radiotherapy: a retrospective study 高温与胸部放疗后放射性肺炎的低发病率相关：一项回顾性研究

BMC Cancer

IF3.4

2025-11-10

OAAI

Wentao Gao; Jiafeng Liang; Lingling Wang; Yanyan Zhao; Shenglin Ma; Lucheng Zhu

Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients 贝伐珠单抗可降低非小细胞肺癌患者中PD-L1（非PD-1）抑制剂相关肺炎的发生率。

Cancer Immunology, Immunotherapy

IF0

2025-10-10

OAAI

Linling Wang; Yasi Xu; Yanyan Zhao; Bing Xia; Lucheng Zhu

Combination of anlotinib and irinotecan as second-line therapy in extensive-stage small-cell lung cancer relapsed within six months: a single-arm phase Ⅱ study 安罗替尼联合伊立替康作为广泛期小细胞肺癌六个月内复发患者的二线治疗方案：一项单臂Ⅱ期研究

Lung Cancer

IF4.4

2025-06-20

OAAI

Minna Zhang; Yi Tang; Jiafeng Liang; Lucheng Zhu; Bing Wang; Kaicheng Pan; Xiao Xu; Xueqin Chen; Bing Xia

Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice (vol 38, pg 233, 2017)阿法替尼（afatinib）作为一种不可逆的ErbB家族阻断剂，在治疗小鼠非小细胞肺癌颅内转移灶中的疗效（vol 38, pg 233, 2017）

ACTA PHARMACOLOGICA SINICA

IF8.4

2025-04-09

PREAI

Zhang, SR; Zhu, LC; Jiang, YP; Zhang, J; Xu, RJ; Xu, YS; Xia, B; Ma, SL

Efficacy analysis of brain radiotherapy in EGFR mutation non-small cell lung cancer with brain metastasis: a retrospective study EGFR突变非小细胞肺癌脑转移患者脑部放射治疗疗效分析：一项回顾性研究

DISCOVER ONCOLOGY

IF2.9

2025-04-08

OAAI

Pan, Kaicheng; Wang, Bing; Xu, Xiao; Tang, Yi; Liang, Jiafeng; Ma, Shenglin; Xia, Bing; Zhu, Lucheng

The role of PD-L1 in EGFR-mutant non-small cell lung cancer PD-L1在EGFR突变型非小细胞肺癌中的作用

DISCOVER ONCOLOGY

IF2.9

2025-03-12

OAAI

Gao, Wentao; Wang, Lingling; Zhao, Yanyan; Zhu, Lucheng

SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer (vol 524, pg 268,2022)

CANCER LETTERS

IF10.1

2025-02-01

OAAI

Zhang, Jingjing; Wu, Qiong; Zhu, Lucheng; Xie, Shujun; Tu, Linglan; Yang, Yuhong; Wu, Kan; Zhao, Yanyan; Wang, Yuqing; Xu, Yasi; Chen, Xueqin; Ma, Shenglin; Zhang, Shirong

Role of TLR7 expression in cancer: impact on immune activation and prognostic evaluation

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2024-07-29

OAAI

Liang, Jiafeng; Huang, Jie; Tang, Yi; Zhang, Minna; Zhu, Lucheng; Xia, Bing

Second-line pembrolizumab (pembro) in Chinese patients (pts) with advanced melanoma: Long-term follow-up of the phase I KEYNOTE-151 study

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Si, L.; Zhang, X.; Shu, Y.; Pan, H.; Wu, D.; Liu, J.; Mao, L.; Wang, X.; Wen, X.; Gu, Y.; Zhu, L.; Lan, S.; Cai, X.; Diede, S.; Chen, S. S.; Hu, H.; Guo, J.

Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report

FRONTIERS IN ONCOLOGY

IF3.3

2022-11-09

OAAI

Zhu, Lucheng; Ma, Shenglin; Xia, Bing

SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer SERPINE2/PN-1通过激活ATM调节肺癌的DNA损伤反应和放射抗性

CANCER LETTERS

IF10.1

2022-01-01

OAAI

Zhang, Jingjing; Wu, Qiong; Zhu, Lucheng; Xie, Shujun; Tu, Linglan; Yang, Yuhong; Wu, Kan; Zhao, Yanyan; Wang, Yuqing; Xu, Yasi; Chen, Xueqin; Ma, Shenglin; Zhang, Shirong

Cancer-associated fibroblasts in non-small cell lung cancer: Recent advances and future perspectives 非小细胞肺癌中癌症相关成纤维细胞: 最新进展和未来展望

CANCER LETTERS

IF10.1

2021-08-01

PREAI

Zhang, Hongfang; Jiang, Hong; Zhu, Lucheng; Li, Jiawei; Ma, Shenglin

Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha 地西他滨通过上调叶酸受体 α 对培美曲塞的放射敏感性

FRONTIERS IN ONCOLOGY

IF3.3

2021-05-17

OAAI

Wang, Yuqing; Huang, Jie; Wu, Qiong; Zhang, Jingjing; Ma, Zhiyuan; Zhu, Lucheng; Xia, Bin; Ma, Shenglin; Zhang, Shirong

Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study

BMC CANCER

IF3.4

2021-05-07

OAAI

Zhu, Lucheng; Zou, Changlin; Zhang, Zhanchun; Wang, Jianfang; Yang, Li; Rao, Chuangzhou; Yang, Zhiping; Liang, Jiafeng; Xia, Bing; Shenglin, M. A.

Deep learning-based automatic delineation of the hippocampus by MRI: geometric and dosimetric evaluation

RADIATION ONCOLOGY

IF3.2

2021-01-14

OAAI

Pan, Kaicheng; Zhao, Lei; Gu, Song; Tang, Yi; Wang, Jiahao; Yu, Wen; Zhu, Lucheng; Feng, Qi; Su, Ruipeng; Xu, Zhiyong; Li, Xiadong; Ding, Zhongxiang; Fu, Xiaolong; Ma, Shenglin; Yan, Jun; Kang, Shigong; Zhou, Tao; Xia, Bing

Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study

BMC CANCER

IF3.4

2020-08-31

OAAI

Zhu, Lucheng; Xu, Zhizheng; Wu, Yajun; Liu, Pengyuan; Qian, Jianing; Yu, Shuhuan; Xia, Bing; Lai, Jianjun; Ma, Shenglin; Wu, Zhibing

Intraperitoneal perfusion chemotherapy and whole abdominal hyperthermia using external radiofrequency following radical D2 resection for treatment of advanced gastric cancer

INTERNATIONAL JOURNAL OF HYPERTHERMIA

IF3

2019-03-04

OAAI

Zhu, Lucheng; Xu, Yasi; Shan, Yuqiang; Zheng, Ruzhen; Wu, Zhibing; Ma, Shenglin